Overview of Dr. Li
Dr. Jia Li is an oncologist in Commack, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and St. Catherine of Siena Hospital. She received her medical degree from Tianjin Medical University and has been in practice 22 years. She is one of 497 doctors at Memorial Sloan Kettering Cancer Center and one of 82 doctors at St. Catherine of Siena Hospital who specialize in Oncology. She has more than 30 publications and over 500 citings.
Office
650 Commack Road
Commack, NY 11725
Education & Training
- Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2004 - 2007
- Tianjin Medical UniversityClass of 1995
Certifications & Licensure
- FL State Medical License 2022 - Present
- NJ State Medical License 2019 - 2025
- NY State Medical License 2010 - 2025
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 4 citationsClinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer.Melissa A Lumish, Henry Walch, Steven B Maron, Walid Chatila, Yelena Kemel
Journal of the National Cancer Institute. 2024-02-08 - 4 citationsClinical Importance of Clonal Hematopoiesis in Metastatic Gastrointestinal Tract Cancers.Bill H Diplas, Ryan Ptashkin, Joanne F Chou, Shalom Sabwa, Michael B Foote
JAMA Network Open. 2023-02-01 - 3 citationsCirculating tumor and invasive cell expression profiling predicts effective therapy in pancreatic cancer.Kenneth H Yu, Jennifer Park, Avni Mittal, Ghassan K Abou-Alfa, Imane El Dika
Cancer. 2022-08-01
Journal Articles
- Macrophage Migration Inhibitory Factor Mediates Metabolic Dysfunction Induced by Atypical Antipsychotic TherapyJia Li, Lawrence Young, Richard Bucala, The Journal of Clinical Investigation
Press Mentions
- Phase 2 Study of Parsaclisib (INCB050465), a Highly Selective, Next-Generation PI3Kδ Inhibitor, in Relapsed or Refractory Diffuse Large B-cell Lymphoma (CITADEL-202)November 3rd, 2020
- Scientists Develop Highly Effective Tumor Detection Strategy for Common Childhood Brain TumorsOctober 20th, 2020
- Suny Downstate Medical Center ReviewsAugust 1st, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: